Triglyceride/HDL-cholesterol ratio is an independent predictor for coronary heart disease in a population of Iranian men

Nutrition, Metabolism and Cardiovascular Diseases

Volumn 19, Issue 6, 2009, Pages 401-408

  Hadaegh, F ^a   Khalili, D ^a   Ghasemi, A ^a   Tohidi, M ^a   Sheikholeslami, F ^a   Azizi, F ^a  

^a SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Coronary heart disease; HDL cholesterol; Triglycerides; Triglycerides HDL cholesterol ratio

Indexed keywords

BIOLOGICAL MARKER; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; ASIAN; BLOOD; CORONARY ARTERY DISEASE; CROSS-SECTIONAL STUDY; ETHNOLOGY; FOLLOW UP; HUMAN; IRAN; MALE; METABOLIC SYNDROME X; MIDDLE AGED; PREDICTION AND FORECASTING; PREVALENCE; PROPORTIONAL HAZARDS MODEL; PROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; TIME;

ADULT; AGED; AGED, 80 AND OVER; ASIAN CONTINENTAL ANCESTRY GROUP; BIOLOGICAL MARKERS; CHOLESTEROL, HDL; CORONARY DISEASE; CROSS-SECTIONAL STUDIES; FOLLOW-UP STUDIES; HUMANS; IRAN; MALE; METABOLIC SYNDROME X; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PREVALENCE; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; TIME FACTORS; TRIGLYCERIDES;

EID: 67449086719     PISSN: 09394753     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.numecd.2008.09.003     Document Type: Article

References (30)

1. Executive summary of the Third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA 285 (2001) 2486-2497
2. Hokanson J.E., and Austin M.A. Plasma triglyceride level is a risk factor for cardiovascular disease independent of high-density lipoprotein cholesterol level: a meta-analysis of population-based prospective studies. J Cardiovasc Risk 3 (1996) 213-219
3. McLaughlin T., Abbasi F., Cheal K., Chu J., Lamendola C., and Reaven G. Use of metabolic markers to identify overweight individuals who are insulin resistant. Ann Intern Med 139 (2003) 802-809
4. Barzi F., Patel A., Woodward M., Lawes C.M., Ohkubo T., Gu D., et al. A comparison of lipid variables as predictors of cardiovascular disease in the Asia Pacific region. Ann Epidemiol 15 (2005) 405-413
5. Gaziano J.M., Hennekens C.H., O'Donnell C.J., Breslow J.L., and Buring J.E. Fasting triglycerides, high-density lipoprotein, and risk of myocardial infarction. Circulation 96 (1997) 2520-2525
6. Jeppesen J., Hein H.O., Suadicani P., and Gyntelberg F. Low triglycerides-high high-density lipoprotein cholesterol and risk of ischemic heart disease. Arch Intern Med 161 (2001) 361-366
7. Rizos E., and Mikhailidis D.P. Are high-density lipoprotein and triglyceride levels important in secondary prevention: impressions from the BIP and VA-HIT trials. Int J Cardiol 82 (2002) 199-207 [discussion-8]
8. Hadaegh F., Harati H., Ghanbarian A., and Azizi F. Association of total cholesterol versus other serum lipid parameters with the short-term prediction of cardiovascular outcomes: Tehran Lipid and Glucose Study. Eur J Cardiovasc Prev Rehabil 13 (2006) 571-577
9. Azizi F., Rahmani M., Emami H., Mirmiran P., Hajipour R., Madjid M., et al. Cardiovascular risk factors in an Iranian urban population: Tehran Lipid and Glucose Study (phase 1). Soz Praventivmed 47 (2002) 408-426
10. Azizi F., Salehi P., Etemadi A., and Zahedi-Asl S. Prevalence of metabolic syndrome in an urban population: Tehran Lipid and Glucose Study. Diabetes Res Clin Pract 61 (2003) 29-37
11. Azizi F., Raiszadeh F., Salehi P., Rahmani M., Emami H., Ghanbarian A., et al. Determinants of serum HDL-C level in a Tehran urban population: the Tehran Lipid and Glucose Study. Nutr Metab Cardiovasc Dis 12 (2002) 80-89
12. Azizi F., Rahmani M., Emami H., and Madjid M. Tehran Lipid and Glucose Study: rationale and design. CVD Prevention 3 (2000) 242-247
13. Luepker R.V., Apple F.S., Christenson R.H., Crow R.S., Fortmann S.P., Goff D., et al. Case definitions for acute coronary heart disease in epidemiology and clinical research studies: a statement from the AHA Council on epidemiology and prevention; AHA Statistics Committee; World Heart Federation Council on epidemiology and prevention; the European Society of Cardiology Working Group on epidemiology and prevention; Centers for Disease Control and Prevention; and the National Heart, Lung, and Blood Institute. Circulation 108 (2003) 2543-2549
14. Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 26 Suppl. 1 (2003) S5-S20
15. Onat A., Sari I., Yazici M., Can G., Hergenc G., and Avci G.S. Plasma triglycerides, an independent predictor of cardiovascular disease in men: a prospective study based on a population with prevalent metabolic syndrome. Int J Cardiol 108 (2006) 89-95
16. Grundy S.M., Brewer Jr. H.B., Cleeman J.I., Smith Jr. S.C., and Lenfant C. Definition of metabolic syndrome: report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Circulation 109 (2004) 433-438
17. Ford E.S. The metabolic syndrome and mortality from cardiovascular disease and all-causes: findings from the National Health and Nutrition Examination Survey II Mortality Study. Atherosclerosis 173 (2004) 309-314
18. Esmaillzadeh A., Mirmiran P., and Azizi F. Waist-to-hip ratio is a better screening measure for cardiovascular risk factors than other anthropometric indicators in Tehranian adult men. Int J Obes Relat Metab Disord 28 (2004) 1325-1332
19. Patel A., Huang K.C., Janus E.D., Gill T., Neal B., Suriyawongpaisal P., et al. Is a single definition of the metabolic syndrome appropriate? A comparative study of the USA and Asia. Atherosclerosis 184 (2006) 225-232
20. Sumner A.E., Finley K.B., Genovese D.J., Criqui M.H., and Boston R.C. Fasting triglyceride and the triglyceride-HDL cholesterol ratio are not markers of insulin resistance in African Americans. Arch Intern Med 165 (2005) 1395-1400
21. Alhassan S., Kiazand A., Balise R.R., King A.C., Reaven G.M., and Gardner C.D. Metabolic syndrome: do clinical criteria identify similar individuals among overweight premenopausal women?. Metabolism 57 (2008) 49-56
22. Maruyama C., Imamura K., and Teramoto T. Assessment of LDL particle size by triglyceride/HDL-cholesterol ratio in non-diabetic, healthy subjects without prominent hyperlipidemia. J Atheroscler Thromb 10 (2003) 186-191
23. HDL). Clin Biochem 34 (2001) 583-588
24. Jia L., Long S., Fu M., Yan B., Tian Y., Xu Y., et al. Relationship between total cholesterol/high-density lipoprotein cholesterol ratio, triglyceride/high-density lipoprotein cholesterol ratio, and high-density lipoprotein subclasses. Metabolism 55 (2006) 1141-1148
25. Azizi F., Rahmani M., Ghanbarian A., Emami H., Salehi P., Mirmiran P., et al. Serum lipid levels in an Iranian adults population: Tehran Lipid and Glucose Study. Eur J Epidemiol 18 (2003) 311-319
26. Ghassemi H., Harrison G., and Mohammad K. An accelerated nutrition transition in Iran. Public Health Nutr 5 (2002) 149-155
27. Parks E.J. Effect of dietary carbohydrate on triglyceride metabolism in humans. J Nutr 131 (2001) 2772S-2774S
28. Ezenwaka C.E., and Kalloo R. Carbohydrate-induced hypertriglyceridaemia among West Indian diabetic and non-diabetic subjects after ingestion of three local carbohydrate foods. Indian J Med Res 121 (2005) 23-31
29. Hadaegh F., Bozorgmanesh M.R., Ghasemi A., Harati H., Saadat N., and Azizi F. High prevalence of undiagnosed diabetes and abnormal glucose tolerance in the Iranian urban population: Tehran Lipid and Glucose Study. BMC Public Health 8 (2008) 176
30. Patel A., Barzi F., Jamrozik K., Lam T.H., Ueshima H., Whitlock G., et al. Serum triglycerides as a risk factor for cardiovascular diseases in the Asia-Pacific region. Circulation 110 (2004) 2678-2686